Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer

Journal of Surgical Oncology

Volumn 105, Issue 6, 2012, Pages 520-528

  Chu, Xiao Yuan ^a   Chen, Long Bang ^a   Wang, Jing Hua ^a   Su, Quan Sheng ^a   Yang, Ji Rong ^a   Lin, Yong ^a   Xue, Li Jun ^a   Liu, Xiao Bei ^a   Mo, Xiao Bei ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

colorectal cancer; inhibitor of apoptosis; invasion; metastasis; survivin

Indexed keywords

SURVIVIN;

ADULT; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE EPITHELIUM CELL; LYMPH NODE METASTASIS; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

ADULT; AGED; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; COLORECTAL NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84859733706     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22134     Document Type: Article

References (25)

1. Surlin V, Ioana M, Pleßea IE,: Genetic patterns of metalloproteinases and their tissular inhibitors-clinicopathologic and prognostic significance in colorectal cancer. Rom J Morphol Embryol 2011; 52: 231-236.
2. Shelton BK,: Introduction to colorectal cancer. Semin Oncol Nurs 2002; 18: 2-12.
3. Yang YL, Li XM,: The IAP family: Endogenous caspase inhibitors with multiple biological activities. Cell Res 2000; 10: 169-177.
4. Mita AC, Mita MM, Nawrocki ST, et al.: Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 2008; 14: 5000-5005.
5. Pennati M, Folini M, Zaffaroni N,: Targeting survivin in cancer therapy. Expert Opin Ther Targets 2008; 12: 463-476.
6. Xiaoyuan C, Longbang C, Jinghua W, et al.: Survivin: A potential prognostic marker and chemoradiotherapeutic target for colorectal cancer. Ir J Med Sci 2010; 179: 327-335.
7. Chu X, Chen L, Wang J, et al.: SiRNA-mediated survivin inhibition enhances chemo- or radiosensivity of colorectal cancer cells in tumor-bearing nude mice. Hepatogastroenterology 2010; 57: 1445-1452.
8. Kalliakmanis JG, Kouvidou CH, Latoufis C, et al.: Survivin expression in colorectal carcinomas: Correlations with clinicopathological parameters and survival. Dig Dis Sci 2010; 55: 2958-2964.
9. Shen W, Wang CY, Wang XH, et al.: Oncolytic adenovirus mediated survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo. J Exp Clin Cancer Res 2009; 28: 81.
10. Wittekind C, Neid M,: Cancer invasion and metastasis. Oncology 2005; 69: 14-16.
11. Geiger TR, Peeper DS,: Metastasis mechanisms. Biochim Biophys Acta 2009; 1796: 293-308.
12. LeGolvan MP, Resnick M,: Pathobiology of colorectal cancer hepatic metastases with an emphasis on prognostic factors. J Surg Oncol 2010; 102: 898-908.
13. Kanwar JR, Kamalapuram SK, Kanwar RK,: Targeting survivin in cancer: Patent review. Expert Opin Ther Pat 2010; 20: 1723-1737.
14. O'Driscoll L, Linehan R, Clynes M,: Survivin: Role in normal cells and in pathological conditions. Curr Cancer Drug Targets 2003; 3: 131-152.
15. Li F,: Role of survivin and its splice variants in tumorigenesis. Br J Cancer 2005; 92: 212-216.
16. Duffy MJ, O'Donovan N, Brennan DJ, et al.: Survivin: A promising tumor biomarker. Cancer Lett 2007; 249: 49-60.
17. Sah NK, Khan Z, Khan GJ, et al.: Structural, functional and therapeutic biology of survivin. Cancer Lett 2006; 244: 164-171.
18. Kanwar RK, Cheung CH, Chang JY, et al.: Recent advances in anti-survivin treatments for cancer. Curr Med Chem 2010; 17: 1509-1515.
19. McKenzie JA, Liu T, Goodson AG, et al.: Survivin enhances motility of melanoma cells by supporting Akt activation and {alpha}5 integrin upregulation. Cancer Res 2010; 70: 7927-7937.
20. Zhang M, Coen JJ, Suzuki Y, et al.: Survivin is a potential mediator of prostate cancer metastasis. Int J Radiat Oncol Biol Phys 2010; 78: 1095-1103.
21. Tai CJ, Chin-Sheng H, Kuo LJ, et al.: Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in mahlavu cells. Ann Surg Oncol 2011 [Epub ahead of print].
22. Knight BB, Oprea-Ilies GM, Nagalingam A, et al.: Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin induced migration of breast carcinoma cells. Endocr Relat Cancer 2011; 18: 413-428.
23. Qi G, Tuncel H, Aoki E, et al.: Intracellular localization of survivin determines biological behavior in colorectal cancer. Oncol Rep 2009; 22: 557-562.
24. Shen W, Tu JK, Wang XH, et al.: Oncolytic adenovirus mediated survivin RNA interference and 5-fluorouracil synergistically suppress the lymphatic metastasis of colorectal cancer. Oncol Rep 2010; 24: 1285-1290.
25. Wu JB, Nan QZ, Ma GF, et al.: silencing inhibits invasion and metastasis of human colon carcinoma cell line SW480 in vitro. Nan Fang Yi Ke Da Xue Xue Bao 2007; 27: 951-954.